Inhibition of PrPSc formation by lentiviral gene transfer of PrP containing dominant negative mutations.
Résumé
Currently, there is no treatment to cure transmissible spongiform encephalopathies. By taking advantage of the 'prion-resistant' polymorphisms Q171R and E219K that naturally exist in sheep and humans, respectively, we have evaluated a therapeutic approach of lentiviral gene transfer. Here, we show that VSV-G (vesicular stomatitis virus G glycoprotein) pseudotyped FIV-(feline immunodeficiency virus) derived vectors carrying the mouse Prnp gene in which these mutations have been inserted, are able to inhibit prion replication in chronically prion-infected cells. Because lentiviral tools are able to transduce post-mitotic cells such as neurons or cells of the lymphoreticular system, this result might help the development of gene- or cell-therapy approaches to prion disease.
Domaines
Maladies infectieuses
Fichier principal
JCS_12893E-1.pdf (385.55 Ko)
Télécharger le fichier
JCS_12893E_Fig1.TIF (42.59 Ko)
Télécharger le fichier
JCS_12893E_Fig2.TIF (194.25 Ko)
Télécharger le fichier
JCS_12893E_Fig3.TIF (194.09 Ko)
Télécharger le fichier
JCS_12893E_Fig4_.TIF (984.47 Ko)
Télécharger le fichier
Format : Autre
Format : Autre
Format : Autre
Format : Autre
Loading...